These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3326562)

  • 21. Elimination of beta 2-microglobulin by a new polyacrylonitrile membrane dialyser: mechanism and physiokinetics.
    Akizawa T; Koshikawa S; Nakazawa R; Yoshida T; Kaneko M; Nitadori Y
    Nephrol Dial Transplant; 1989; 4(5):356-65. PubMed ID: 2505186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Plasma Proteins on the Transport and Surface Characteristics of Polysulfone/Polyethersulfone and Asymmetric Cellulose Triacetate High Flux Dialyzers.
    Kim TR; Hadidi M; Motevalian SP; Sunohara T; Zydney AL
    Artif Organs; 2018 Nov; 42(11):1070-1077. PubMed ID: 29774568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do different dialysis-membranes affect beta 2-microglobulin kinetics during chronic hemodialysis?
    Risler T; Braun N; Hanel KD; Kuhlmann U; Skroch D; Müller GA
    Int J Artif Organs; 1994 Nov; 17(11):581-4. PubMed ID: 7744517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statistical and parametric analysis of beta-2-microglobulin removal from uremic patients in high flux hemodialysis.
    Lee CJ; Hsiong CH; Chang YL; Cheng CH; Lian JD
    ASAIO J; 1994; 40(1):62-6. PubMed ID: 8186494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
    Floege J; Koch KM
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W; Szepietowski T
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
    Krieter DH; Lemke HD; Wanner C
    Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymethylmethacrylate membrane with a series of serendipity.
    Sakai Y
    Contrib Nephrol; 2011; 173():137-147. PubMed ID: 21865786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes.
    Randoux C; Gillery P; Georges N; Lavaud S; Chanard J
    Kidney Int; 2001 Oct; 60(4):1571-7. PubMed ID: 11576375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of dialysers with low-flux membranes: significant differences in spite of many similarities.
    Ward RA; Buscaroli A; Schmidt B; Stefoni S; Gurland HJ; Klinkmann H
    Nephrol Dial Transplant; 1997 May; 12(5):965-72. PubMed ID: 9175051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.
    Donadio C; Tognotti D; Caponi L; Paolicchi A
    BMC Nephrol; 2017 Feb; 18(1):68. PubMed ID: 28219328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Albumin loss under the use of the high-performance membrane.
    Tsuchida K; Minakuchi J
    Contrib Nephrol; 2011; 173():76-83. PubMed ID: 21865779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dialyzer membranes as determinants of the adequacy of dialysis.
    Chelamcharla M; Leypoldt JK; Cheung AK
    Semin Nephrol; 2005 Mar; 25(2):81-9. PubMed ID: 15791559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of dialysis membrane on serum beta 2-microglobulin (beta 2M) in chronic haemodialysis patients.
    Farrell J; Bastani B
    Nephrol Dial Transplant; 1997 Apr; 12(4):856. PubMed ID: 9141041
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma protein adsorption to highly permeable hemodialysis membranes.
    Clark WR; Macias WL; Molitoris BA; Wang NH
    Kidney Int; 1995 Aug; 48(2):481-8. PubMed ID: 7564116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers.
    Ouseph R; Hutchison CA; Ward RA
    Nephrol Dial Transplant; 2008 May; 23(5):1704-12. PubMed ID: 18156455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.